- Home
- NEN vs XGN Comparison
NEN vs XGN Comparison
Compare NEN & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEN
- XGN
- Stock Information
- Founded
- NEN 1977
- XGN 2002
- Country
- NEN United States
- XGN United States
- Employees
- NEN N/A
- XGN N/A
- Industry
- NEN Building operators
- XGN Medical Specialities
- Sector
- NEN Real Estate
- XGN Health Care
- Exchange
- NEN Nasdaq
- XGN Nasdaq
- Market Cap
- NEN 250.0M
- XGN 210.4M
- IPO Year
- NEN N/A
- XGN 2019
- Fundamental
- Price
- NEN $71.05
- XGN $11.54
- Analyst Decision
- NEN
- XGN Strong Buy
- Analyst Count
- NEN 0
- XGN 5
- Target Price
- NEN N/A
- XGN $12.00
- AVG Volume (30 Days)
- NEN 824.0
- XGN 286.8K
- Earning Date
- NEN 01-01-0001
- XGN 11-11-2025
- Dividend Yield
- NEN 6.76%
- XGN N/A
- EPS Growth
- NEN 34.86
- XGN N/A
- EPS
- NEN 4.59
- XGN N/A
- Revenue
- NEN $83,884,808.00
- XGN $58,862,000.00
- Revenue This Year
- NEN N/A
- XGN $22.28
- Revenue Next Year
- NEN N/A
- XGN $14.03
- P/E Ratio
- NEN $15.48
- XGN N/A
- Revenue Growth
- NEN 4.96
- XGN 3.89
- 52 Week Low
- NEN $68.41
- XGN $2.38
- 52 Week High
- NEN $84.00
- XGN $11.99
- Technical
- Relative Strength Index (RSI)
- NEN 44.84
- XGN 65.73
- Support Level
- NEN $71.05
- XGN $10.63
- Resistance Level
- NEN $73.50
- XGN $11.99
- Average True Range (ATR)
- NEN 0.55
- XGN 0.33
- MACD
- NEN -0.02
- XGN 0.04
- Stochastic Oscillator
- NEN 0.00
- XGN 68.50
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.
About XGN Exagen Inc.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.